| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glucosamine-6-phosphate deaminase activity | 7.21e-05 | 2 | 170 | 2 | GO:0004342 | |
| Domain | DUF4599 | 3.17e-06 | 12 | 171 | 4 | PF15371 | |
| Domain | DUF4599 | 3.17e-06 | 12 | 171 | 4 | IPR027970 | |
| Domain | Glucosamine6P_isomerase_CS | 8.33e-05 | 2 | 171 | 2 | IPR018321 | |
| Domain | Glucosamine6P_isomerase | 8.33e-05 | 2 | 171 | 2 | IPR004547 | |
| Domain | GLC_GALNAC_ISOMERASE | 8.33e-05 | 2 | 171 | 2 | PS01161 | |
| Domain | HECT | 1.01e-04 | 27 | 171 | 4 | PF00632 | |
| Domain | HECTc | 1.01e-04 | 27 | 171 | 4 | SM00119 | |
| Domain | HECT_dom | 1.01e-04 | 27 | 171 | 4 | IPR000569 | |
| Domain | HECT | 1.01e-04 | 27 | 171 | 4 | PS50237 | |
| Domain | CK1gamma_C | 2.49e-04 | 3 | 171 | 2 | PF12605 | |
| Domain | Casein_kinase-1_gamma_C | 2.49e-04 | 3 | 171 | 2 | IPR022247 | |
| Domain | Tensin_PTB | 4.94e-04 | 4 | 171 | 2 | IPR033929 | |
| Domain | Glc/Gal-6P_isomerase | 4.94e-04 | 4 | 171 | 2 | IPR006148 | |
| Domain | Glucosamine_iso | 4.94e-04 | 4 | 171 | 2 | PF01182 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 1.52e-05 | 65 | 116 | 6 | M39682 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ZXDC PDE4A KIAA0319L LAMA5 SRCAP MBD6 RALGAPA2 BIRC6 RASSF7 BAP1 TRIM7 PPP1R26 NCOR1 KMT2C DIP2A PHLDB1 SHANK2 PTPRS CSNK1G2 GLI1 ZNF335 ANKRD34A ANKRD11 EHMT1 WDR90 DOT1L HERC1 IL17RD DYNC1H1 NOTCH1 | 5.90e-14 | 1105 | 176 | 30 | 35748872 |
| Pubmed | 1.87e-11 | 6 | 176 | 5 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 1.87e-11 | 6 | 176 | 5 | 25930072 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | SLC11A2 SPTBN2 KIAA0319L KIAA1549 RAB11FIP1 RALGAPA2 ATP10D JPH1 TBC1D10B PHLDB1 PIEZO2 C1orf226 CSNK1G2 EPHA2 MARCKS NOTCH1 TNS3 VAT1 | 8.27e-10 | 569 | 176 | 18 | 30639242 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | IRF2BP2 RTN4 SPTBN2 MACROH2A1 SPATA31A6 KMT2C ZNF106 DIP2A VPS13D PHLDB1 ANKRD11 HERC1 CTTN PLRG1 BAG6 C8orf33 | 5.88e-09 | 497 | 176 | 16 | 36774506 |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | ZNF821 LGR4 LAMA5 SUPT20HL2 SRCAP RALGAPA2 LARP4 BIRC6 ZNF106 ZNF335 CNDP2 NHS ALPI | 4.84e-08 | 363 | 176 | 13 | 14691545 |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | WWP2 DOCK10 INPP4B JPH1 DIP2A TBC1D10B PHLDB1 NDRG1 PTPRS CSNK1G2 EPHA2 MARCKS VAT1 | 7.51e-08 | 377 | 176 | 13 | 38117590 |
| Pubmed | 1.23e-07 | 24 | 176 | 5 | 32212159 | ||
| Pubmed | HECW1 RTEL1 DOCK10 PTPN23 BIRC6 HEPH BAP1 KMT2C PHLDB1 EHMT1 | 2.50e-07 | 225 | 176 | 10 | 12168954 | |
| Pubmed | ZFAT PSD2 NACAD AXIN1 NCOR1 KMT2C STARD9 MKI67 ANKRD34A TNS3 | 3.45e-07 | 233 | 176 | 10 | 37704626 | |
| Pubmed | SPTBN2 KIAA1549 PTPN23 TNS2 BCKDHA RAB11FIP1 BIRC6 CEP350 FBXO38 NCOR1 TBC1D10B C1orf226 PTPRS MKI67 NHS HERC1 NOTCH1 TNS3 PPP1R12C VAT1 | 4.16e-07 | 1049 | 176 | 20 | 27880917 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | WWP2 RAB11FIP1 CBL ZNRF2 RASSF7 CEP350 ZNF106 TBC1D10B VPS13D PHLDB1 DENND1B NDRG1 YAP1 STARD9 ANKRD11 NHS TNS3 PPP1R12C | 4.40e-07 | 861 | 176 | 18 | 36931259 |
| Pubmed | ZXDC SHLD2 ZNF821 ACD RALGAPA2 LARP4 SEZ6L2 CEP350 TBC1D10B VPS13D SHANK2 CSNK1G2 C6orf120 HERC1 | 1.35e-06 | 568 | 176 | 14 | 9110174 | |
| Pubmed | 1.43e-06 | 17 | 176 | 4 | 37315133 | ||
| Pubmed | A "double adaptor" method for improved shotgun library construction. | ZXDC SHLD2 ZNF821 ACD RALGAPA2 LARP4 SEZ6L2 CEP350 TBC1D10B VPS13D SHANK2 CSNK1G2 C6orf120 HERC1 | 1.52e-06 | 574 | 176 | 14 | 8619474 |
| Pubmed | TPR WWP2 RAB11FIP1 CBL PRKD3 NCOR1 NDRG1 EHMT2 YAP1 MKI67 NHS CTTN BAG6 | 1.94e-06 | 503 | 176 | 13 | 16964243 | |
| Pubmed | Loss of Wiz Function Affects Methylation Pattern in Palate Development and Leads to Cleft Palate. | 2.31e-06 | 19 | 176 | 4 | 34150743 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | RTN4 SPTBN2 MACROH2A1 CBL TBC1D10B NDRG1 SHANK2 YAP1 EPHA2 NHS CTTN MARCKS NOTCH1 | 6.82e-06 | 565 | 176 | 13 | 25468996 |
| Pubmed | 7.00e-06 | 8 | 176 | 3 | 19660449 | ||
| Pubmed | 7.00e-06 | 8 | 176 | 3 | 28530678 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | WWP2 RTN4 LGR4 PCDHA12 TRIM7 KIAA0319 CCNT1 NDRG1 PTPRS EPHA2 C6orf120 CNDP2 HERC1 CTTN BAG6 MARCKS NOTCH1 RAD17 | 8.17e-06 | 1061 | 176 | 18 | 33845483 |
| Pubmed | System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes. | 8.69e-06 | 26 | 176 | 4 | 26949039 | |
| Pubmed | GNPDA1 HECW1 RTEL1 SPTBN2 PTPN23 RALGAPA2 BIRC6 PRX CEP350 PPP1R26 VPS13D NUP160 | 8.89e-06 | 493 | 176 | 12 | 15368895 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR IRF2BP2 ARID4A BAP1 FBXO38 NCOR1 ZNF106 TBC1D10B NDRG1 YAP1 ZNF335 MKI67 CTTN BAG6 ALPI | 1.03e-05 | 774 | 176 | 15 | 15302935 |
| Pubmed | 1.05e-05 | 9 | 176 | 3 | 31481792 | ||
| Pubmed | IRF2BP2 ARID4A SRCAP MBD6 LARP4 BAP1 ZIC3 RNF214 NCOR1 KMT2C EHMT2 YAP1 UBXN7 MKI67 EHMT1 UQCRC1 PAX7 DOT1L HERC1 CTTN DYNC1H1 | 1.24e-05 | 1429 | 176 | 21 | 35140242 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | CENPT ARID4A CHD1L SRCAP BAP1 BMI1 FBXO38 CCNT1 EHMT2 MKI67 EHMT1 DOT1L METAP2 | 1.48e-05 | 608 | 176 | 13 | 36089195 |
| Pubmed | 1.55e-05 | 104 | 176 | 6 | 9205841 | ||
| Pubmed | 1.57e-05 | 30 | 176 | 4 | 24073291 | ||
| Pubmed | 1.57e-05 | 30 | 176 | 4 | 17257418 | ||
| Pubmed | ZXDC RTN4 POU3F3 ZBTB7B CBL BIRC6 KMT2C NDRG1 GLI1 NR2E1 MKI67 SEBOX PAX7 CTTN | 1.68e-05 | 709 | 176 | 14 | 22988430 | |
| Pubmed | Functional genomic landscape of cancer-intrinsic evasion of killing by T cells. | IRF2BP2 ZFAT ARID4A SUPT20HL2 SRCAP LARP4 CEP350 CCNT1 UBXN7 DOT1L NUP160 | 2.35e-05 | 457 | 176 | 11 | 32968282 |
| Pubmed | Role of GLI1 and NDRG1 in Increased Resistance to Apoptosis Induction. | 2.55e-05 | 2 | 176 | 2 | 26349604 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 782924 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 12616532 | ||
| Pubmed | Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability. | 2.55e-05 | 2 | 176 | 2 | 22726846 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 32015216 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 33609736 | ||
| Pubmed | Gli1 interacts with YAP1 to promote tumorigenesis in esophageal squamous cell carcinoma. | 2.55e-05 | 2 | 176 | 2 | 31957872 | |
| Pubmed | Notch-1 and Ki-67 receptor as predictors for the recurrence and prognosis of Kimura's disease. | 2.55e-05 | 2 | 176 | 2 | 24966950 | |
| Pubmed | c-Cbl binding and ubiquitin-dependent lysosomal degradation of membrane-associated Notch1. | 2.55e-05 | 2 | 176 | 2 | 11777909 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 34619147 | ||
| Pubmed | Evidence of a sex-dependent restrictive epigenome in schizophrenia. | 2.55e-05 | 2 | 176 | 2 | 25935252 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 19531572 | ||
| Pubmed | G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription. | 2.55e-05 | 2 | 176 | 2 | 18818694 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 29554304 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 25380126 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 29069077 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 32976761 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 10575011 | ||
| Pubmed | EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression. | 2.55e-05 | 2 | 176 | 2 | 26320100 | |
| Pubmed | EHMT1/EHMT2 in EMT, cancer stemness and drug resistance: emerging evidence and mechanisms. | 2.55e-05 | 2 | 176 | 2 | 34954891 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 29855824 | ||
| Pubmed | Two mammalian glucosamine-6-phosphate deaminases: a structural and genetic study. | 2.55e-05 | 2 | 176 | 2 | 12965206 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 33283949 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 12147253 | ||
| Pubmed | MLL3 suppresses tumorigenesis through regulating TNS3 enhancer activity. | 2.55e-05 | 2 | 176 | 2 | 33824309 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 37894922 | ||
| Pubmed | CHD1L promotes EOC cell invasiveness and metastasis via the regulation of METAP2. | 2.55e-05 | 2 | 176 | 2 | 32922205 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 25637356 | ||
| Pubmed | G9a/GLP Complex Maintains Imprinted DNA Methylation in Embryonic Stem Cells. | 2.55e-05 | 2 | 176 | 2 | 27052169 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 33307343 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 25365549 | ||
| Pubmed | PI3K/AKT signaling inhibits NOTCH1 lysosome-mediated degradation. | 2.55e-05 | 2 | 176 | 2 | 26052821 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 21395182 | ||
| Pubmed | BMI-1 suppresses contact inhibition and stabilizes YAP in Ewing sarcoma. | 2.55e-05 | 2 | 176 | 2 | 21170084 | |
| Pubmed | [Expression and significance of Bmi-1 and Ki67 in colorectal carcinoma tissues]. | 2.55e-05 | 2 | 176 | 2 | 19080002 | |
| Pubmed | EphA2-to-YAP pathway drives gastric cancer growth and therapy resistance. | 2.55e-05 | 2 | 176 | 2 | 31376289 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 18264113 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 28615290 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 31775874 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 25079219 | ||
| Pubmed | Yes-associated protein (YAP) promotes cell survival by inhibiting proapoptotic dendrin signaling. | 2.55e-05 | 2 | 176 | 2 | 23667252 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 15774718 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 34351699 | ||
| Pubmed | A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification. | 2.55e-05 | 2 | 176 | 2 | 17855633 | |
| Pubmed | Hippo pathway/Yap regulates primary enamel knot and dental cusp patterning in tooth morphogenesis. | 2.55e-05 | 2 | 176 | 2 | 26318014 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 9742101 | ||
| Pubmed | 2.71e-05 | 12 | 176 | 3 | 25005473 | ||
| Pubmed | Bmi1 regulates murine intestinal stem cell proliferation and self-renewal downstream of Notch. | 2.71e-05 | 12 | 176 | 3 | 25480918 | |
| Pubmed | TPR PDE4A HECW1 SPTBN2 DDN MACROH2A1 SIPA1 KIAA0319 NCOR1 TRIM67 SHANK2 EHMT2 PTPRS EHMT1 CTTN DYNC1H1 | 3.41e-05 | 963 | 176 | 16 | 28671696 | |
| Pubmed | 3.51e-05 | 13 | 176 | 3 | 16055717 | ||
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | TPR RTN4 PTPN23 TNS2 BCKDHA RASSF7 CEP350 MKI67 HERC1 MARCKS DYNC1H1 PPP1R12C | 3.89e-05 | 573 | 176 | 12 | 28330616 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | RTN4 POU3F3 PODXL2 MACROH2A1 CBL GDE1 AXIN1 ZIC3 CCNT1 ZNF106 TBC1D10B C6orf120 MKI67 PLRG1 BAG6 NUP160 VAT1 MAF | 4.29e-05 | 1203 | 176 | 18 | 29180619 |
| Pubmed | Cell-fate transition and determination analysis of mouse male germ cells throughout development. | 4.45e-05 | 14 | 176 | 3 | 34824237 | |
| Pubmed | 5.02e-05 | 128 | 176 | 6 | 23858473 | ||
| Pubmed | 5.54e-05 | 15 | 176 | 3 | 29045729 | ||
| Pubmed | Down-regulation of active ACK1 is mediated by association with the E3 ubiquitin ligase Nedd4-2. | 5.54e-05 | 15 | 176 | 3 | 19144635 | |
| Pubmed | Ascl1 and Gsh1/2 control inhibitory and excitatory cell fate in spinal sensory interneurons. | 5.54e-05 | 15 | 176 | 3 | 16715081 | |
| Pubmed | 5.69e-05 | 335 | 176 | 9 | 15741177 | ||
| Pubmed | RAB11FIP1 RALGAPA2 CBL JPH1 TBC1D10B PHLDB1 C1orf226 EPHA2 NHS VAT1 | 6.19e-05 | 421 | 176 | 10 | 36976175 | |
| Pubmed | 6.23e-05 | 339 | 176 | 9 | 37232246 | ||
| Pubmed | TPR WWP2 RTN4 AXIN1 CCNT1 NCOR1 NDRG1 YAP1 EPHA2 MKI67 CNDP2 NHS OXSM DOT1L CTTN PLRG1 DYNC1H1 TNS3 | 6.78e-05 | 1247 | 176 | 18 | 27684187 | |
| Pubmed | 6.80e-05 | 16 | 176 | 3 | 28803780 | ||
| Pubmed | WWP2 RTN4 SPTBN2 KIAA1549 BCKDHA MACROH2A1 RAB11FIP1 SNX29 JPH1 DIP2A COCH EHMT2 EPHA2 ANKRD11 EHMT1 CNDP2 NME4 PLRG1 BAG6 MARCKS | 6.98e-05 | 1487 | 176 | 20 | 33957083 | |
| Pubmed | WWP2 SPTBN2 MACROH2A1 CHD1L LARP4 MAP3K1 CEP350 PRKD3 TBC1D10B STARD9 EPHA2 CSNK1G1 MKI67 NME4 PLRG1 METAP2 C8orf33 MARCKS DYNC1H1 | 7.24e-05 | 1371 | 176 | 19 | 36244648 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 7.37e-05 | 430 | 176 | 10 | 35044719 | |
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 23112189 | ||
| Pubmed | De novo point mutations in patients diagnosed with ataxic cerebral palsy. | 7.61e-05 | 3 | 176 | 2 | 25981959 | |
| Pubmed | Cortactin promotes colorectal cancer cell proliferation by activating the EGFR-MAPK pathway. | 7.61e-05 | 3 | 176 | 2 | 27903975 | |
| Interaction | TOP3B interactions | ZXDC PDE4A RTEL1 SPTBN2 KIAA0319L LAMA5 MACROH2A1 SRCAP MBD6 RALGAPA2 LARP4 BIRC6 RASSF7 BAP1 TRIM7 PPP1R26 NCOR1 KMT2C DIP2A PHLDB1 SHANK2 PTPRS CSNK1G2 GLI1 ZNF335 ANKRD34A ANKRD11 EHMT1 WDR90 DOT1L HERC1 IL17RD DYNC1H1 NOTCH1 | 5.99e-08 | 1470 | 170 | 34 | int:TOP3B |
| Interaction | LAMTOR1 interactions | SPTBN2 KIAA0319L KIAA1549 PTPN23 RAB11FIP1 ZNRF2 SNX29 AXIN1 BAP1 JPH1 PRKD3 DIP2A TBC1D10B TRIM67 NDRG1 C1orf226 YAP1 CSNK1G2 EPHA2 MARCKS NOTCH1 VAT1 | 1.95e-07 | 722 | 170 | 22 | int:LAMTOR1 |
| Interaction | FBXO22 interactions | IRF2BP2 RTN4 SPTBN2 MACROH2A1 SPATA31A6 NCOR1 KMT2C ZNF106 DIP2A VPS13D PHLDB1 TRIM67 ANKRD11 HERC1 CTTN PLRG1 BAG6 C8orf33 | 7.64e-07 | 540 | 170 | 18 | int:FBXO22 |
| Interaction | AMDHD2 interactions | 9.87e-07 | 10 | 170 | 4 | int:AMDHD2 | |
| Interaction | RAC3 interactions | SLC11A2 WWP2 SPTBN2 LGR4 KIAA1549 PODXL2 RAB11FIP1 JPH1 DIP2A TBC1D10B NDRG1 C1orf226 PTPRS EPHA2 ANKRD11 NHS MARCKS NOTCH1 | 5.21e-06 | 619 | 170 | 18 | int:RAC3 |
| Interaction | RHOQ interactions | WWP2 SPTBN2 KIAA1549 MACROH2A1 RAB11FIP1 RALGAPA2 JPH1 TBC1D10B NDRG1 C1orf226 PTPRS EPHA2 MARCKS NOTCH1 TNS3 | 5.38e-06 | 442 | 170 | 15 | int:RHOQ |
| Interaction | KDM1B interactions | 9.28e-06 | 58 | 170 | 6 | int:KDM1B | |
| Interaction | TRRAP interactions | MKRN3 IRF2BP2 TFAP2D RBL1 LAMA5 RAB11FIP1 SRCAP FBXO38 NCOR1 PHLDB1 TRIM67 EHMT2 YAP1 ZC3HAV1L MKI67 EHMT1 DOT1L PLRG1 NUP160 DYNC1H1 | 1.19e-05 | 790 | 170 | 20 | int:TRRAP |
| Interaction | NFIC interactions | 1.22e-05 | 210 | 170 | 10 | int:NFIC | |
| Interaction | UBE2L3 interactions | 1.27e-05 | 211 | 170 | 10 | int:UBE2L3 | |
| Interaction | CTNNAL1 interactions | 1.80e-05 | 65 | 170 | 6 | int:CTNNAL1 | |
| Interaction | RHOJ interactions | SLC11A2 WWP2 SPTBN2 DOCK10 LGR4 RAB11FIP1 RALGAPA2 JPH1 DIP2A TBC1D10B NDRG1 C1orf226 PTPRS CSNK1G2 EPHA2 MARCKS NOTCH1 | 2.68e-05 | 633 | 170 | 17 | int:RHOJ |
| Interaction | RHOB interactions | SLC11A2 WWP2 SPTBN2 KIAA1549 MACROH2A1 RAB11FIP1 RALGAPA2 SNX29 BAP1 JPH1 PRKD3 DIP2A TBC1D10B NDRG1 PTPRS EPHA2 HERC1 NUP160 MARCKS NOTCH1 | 2.86e-05 | 840 | 170 | 20 | int:RHOB |
| Interaction | TOM1 interactions | 2.87e-05 | 104 | 170 | 7 | int:TOM1 | |
| Interaction | LRRIQ1 interactions | 2.99e-05 | 43 | 170 | 5 | int:LRRIQ1 | |
| Interaction | VASP interactions | IRF2BP2 WWP2 PTPN23 CBL CEP350 BMI1 TBC1D10B TRIM67 YAP1 NHS NUP160 | 4.19e-05 | 294 | 170 | 11 | int:VASP |
| Interaction | HDAC2 interactions | IRF2BP2 ARID4A RBL1 WWP2 HLX MACROH2A1 ZBTB7B BAP1 PRKD3 BMI1 NCOR1 TRIM67 EHMT2 YAP1 GLI1 NR2E1 MKI67 EHMT1 DYNC1H1 MAF | 4.32e-05 | 865 | 170 | 20 | int:HDAC2 |
| Interaction | MCAM interactions | WWP2 DOCK10 INPP4B JPH1 DIP2A TBC1D10B PHLDB1 TRIM67 NDRG1 PTPRS CSNK1G2 EPHA2 MARCKS VAT1 | 4.50e-05 | 468 | 170 | 14 | int:MCAM |
| Interaction | PPP1CB interactions | WWP2 SPTBN2 SIPA1 RASSF7 BAP1 NCOR1 ZNF106 TRIM67 YAP1 GLI1 DOT1L CTTN DYNC1H1 PPP1R12C | 4.60e-05 | 469 | 170 | 14 | int:PPP1CB |
| Interaction | YWHAG interactions | LGR4 TNS2 SIPA1 RAB11FIP1 CBL ZNRF2 RASSF7 MAP3K1 BAP1 CEP350 ZNF106 TBC1D10B VPS13D PHLDB1 DENND1B TRIM67 NDRG1 YAP1 STARD9 ANKRD34A ANKRD11 NHS DYNC1H1 TNS3 PPP1R12C | 4.91e-05 | 1248 | 170 | 25 | int:YWHAG |
| Interaction | WDR5 interactions | ZXDC TPR WWP2 MACROH2A1 MBD6 ZBTB7B BAP1 BMI1 KMT2C TRIM67 EHMT2 YAP1 ZNF335 CNDP2 PAX7 DOT1L PLRG1 METAP2 BAG6 NUP160 MARCKS DYNC1H1 VAT1 | 5.39e-05 | 1101 | 170 | 23 | int:WDR5 |
| Interaction | FMNL3 interactions | 5.69e-05 | 49 | 170 | 5 | int:FMNL3 | |
| Interaction | FXR2 interactions | WWP2 RTN4 ZBTB7B AXIN1 BAP1 BMI1 RNF214 PHLDB1 TRIM67 GLI1 MKI67 DOT1L PPP1R12C | 7.61e-05 | 430 | 170 | 13 | int:FXR2 |
| Interaction | UBE2D2 interactions | MKRN3 HECW1 WWP2 CBL ZNRF2 MAP3K1 TRIM7 BMI1 TRIM67 UBXN7 HERC1 | 8.47e-05 | 318 | 170 | 11 | int:UBE2D2 |
| Interaction | RHOG interactions | SLC11A2 WWP2 RTN4 SPTBN2 KIAA0319L KIAA1549 PODXL2 MACROH2A1 RAB11FIP1 RALGAPA2 JPH1 TRIM67 NDRG1 C1orf226 EPHA2 NME4 MARCKS NOTCH1 ALPI VAT1 | 8.68e-05 | 910 | 170 | 20 | int:RHOG |
| Interaction | ASH2L interactions | 8.76e-05 | 265 | 170 | 10 | int:ASH2L | |
| Interaction | DPYSL3 interactions | 8.88e-05 | 86 | 170 | 6 | int:DPYSL3 | |
| Interaction | RAC1 interactions | SLC11A2 WWP2 SPTBN2 LGR4 KIAA1549 GOLGA8R SIPA1 RAB11FIP1 BAP1 JPH1 TBC1D10B TRIM67 C1orf226 PTPRS EPHA2 NHS METAP2 BAG6 NUP160 MARCKS NOTCH1 TNS3 | 9.09e-05 | 1063 | 170 | 22 | int:RAC1 |
| Interaction | RPL39P5 interactions | 9.85e-05 | 29 | 170 | 4 | int:RPL39P5 | |
| Interaction | RAB35 interactions | SPTBN2 KIAA1549 RAB11FIP1 SNX29 JPH1 BMI1 TBC1D10B DENND1B TRIM67 NDRG1 PTPRS EPHA2 NUP160 MARCKS NOTCH1 | 1.08e-04 | 573 | 170 | 15 | int:RAB35 |
| Interaction | XRCC5 interactions | TPR RTEL1 WWP2 MACROH2A1 CHD1L ZBTB7B CBL BAP1 BMI1 TRIM67 NDRG1 YAP1 DOT1L DYNC1H1 | 1.24e-04 | 515 | 170 | 14 | int:XRCC5 |
| Interaction | YY1 interactions | SRCAP MBD6 ZBTB7B BAP1 BMI1 CCNT1 TRIM67 EHMT2 MKI67 EHMT1 DOT1L CTTN NOTCH1 | 1.31e-04 | 454 | 170 | 13 | int:YY1 |
| Interaction | YWHAB interactions | TNS2 SIPA1 RAB11FIP1 CBL BAP1 CEP350 ZNF106 TBC1D10B VPS13D PHLDB1 DENND1B TRIM67 YAP1 STARD9 ANKRD34A NHS DOT1L MARCKS DYNC1H1 TNS3 PPP1R12C | 1.32e-04 | 1014 | 170 | 21 | int:YWHAB |
| Interaction | SYNCRIP interactions | WWP2 LARP4 ZBTB7B BAP1 TBC1D10B MYPOP TRIM67 YAP1 MKI67 ANKRD11 CNDP2 NHS DOT1L CTTN PLRG1 METAP2 DYNC1H1 | 1.32e-04 | 721 | 170 | 17 | int:SYNCRIP |
| Interaction | NFIX interactions | 1.37e-04 | 227 | 170 | 9 | int:NFIX | |
| Interaction | CETN2 interactions | 1.37e-04 | 133 | 170 | 7 | int:CETN2 | |
| Interaction | KRT79 interactions | 1.40e-04 | 59 | 170 | 5 | int:KRT79 | |
| Interaction | RAB4A interactions | RTN4 KIAA0319L KIAA1549 PTPN23 RAB11FIP1 SNX29 JPH1 VPS13D TRIM67 NDRG1 EPHA2 CNDP2 NOTCH1 | 1.40e-04 | 457 | 170 | 13 | int:RAB4A |
| Interaction | MYO1C interactions | WWP2 SPTBN2 SIPA1 LARP4 CBL ZIC3 TRIM67 YAP1 EPHA2 PYCARD DOT1L CTTN | 1.45e-04 | 397 | 170 | 12 | int:MYO1C |
| Interaction | UBE2D3 interactions | 1.50e-04 | 283 | 170 | 10 | int:UBE2D3 | |
| Interaction | YWHAH interactions | TNS2 SIPA1 RAB11FIP1 CBL ZNRF2 RASSF7 BAP1 CEP350 ZNF106 TBC1D10B VPS13D PHLDB1 DENND1B TRIM67 NDRG1 YAP1 STARD9 ANKRD11 NHS HERC1 TNS3 PPP1R12C | 1.53e-04 | 1102 | 170 | 22 | int:YWHAH |
| Interaction | ATXN2L interactions | 1.64e-04 | 286 | 170 | 10 | int:ATXN2L | |
| Interaction | FCN1 interactions | 1.65e-04 | 33 | 170 | 4 | int:FCN1 | |
| Interaction | ERBB4 interactions | 1.73e-04 | 184 | 170 | 8 | int:ERBB4 | |
| Interaction | H2BC3 interactions | MACROH2A1 CHD1L SRCAP CBL BAP1 BMI1 KMT2C TRIM67 YAP1 UBXN7 DOT1L PLRG1 | 1.78e-04 | 406 | 170 | 12 | int:H2BC3 |
| Interaction | NUMA1 interactions | WWP2 LGR4 MACROH2A1 SRCAP BIRC6 BMI1 TRIM67 YAP1 MKI67 EHMT1 CNDP2 NUP160 DYNC1H1 | 1.80e-04 | 469 | 170 | 13 | int:NUMA1 |
| Interaction | SRSF2 interactions | TPR WWP2 MACROH2A1 TRIM67 YAP1 EHMT1 DOT1L PLRG1 BAG6 DYNC1H1 | 1.83e-04 | 290 | 170 | 10 | int:SRSF2 |
| Interaction | RHOA interactions | SLC11A2 WWP2 RTN4 SPTBN2 KIAA0319L LGR4 KIAA1549 MACROH2A1 SIPA1 RAB11FIP1 MAP3K1 BAP1 JPH1 VPS13D TRIM67 PTPRS EPHA2 MKI67 NHS LUM BAG6 MARCKS NOTCH1 | 1.92e-04 | 1199 | 170 | 23 | int:RHOA |
| Interaction | TCOF1 interactions | 1.93e-04 | 292 | 170 | 10 | int:TCOF1 | |
| Interaction | HCFC1 interactions | 1.99e-04 | 293 | 170 | 10 | int:HCFC1 | |
| Interaction | UBE2D1 interactions | 2.04e-04 | 294 | 170 | 10 | int:UBE2D1 | |
| Interaction | AKAP8L interactions | 2.08e-04 | 240 | 170 | 9 | int:AKAP8L | |
| Interaction | LAMP2 interactions | SLC11A2 SPTBN2 KIAA0319L KIAA1549 PODXL2 CHD1L RAB11FIP1 RALGAPA2 SNX29 JPH1 TRIM67 YAP1 EPHA2 MARCKS VAT1 | 2.09e-04 | 609 | 170 | 15 | int:LAMP2 |
| Interaction | TK1 interactions | 2.28e-04 | 243 | 170 | 9 | int:TK1 | |
| Interaction | FBXO38 interactions | 2.34e-04 | 145 | 170 | 7 | int:FBXO38 | |
| Interaction | RAB11A interactions | TPR RTN4 KIAA1549 PODXL2 RAB11FIP1 RALGAPA2 BIRC6 JPH1 TRIM67 NDRG1 EPHA2 MKI67 CTTN BAG6 GPR176 MARCKS NOTCH1 VAT1 | 2.35e-04 | 830 | 170 | 18 | int:RAB11A |
| Interaction | TOM1L2 interactions | 2.37e-04 | 66 | 170 | 5 | int:TOM1L2 | |
| Interaction | SPART interactions | 2.40e-04 | 103 | 170 | 6 | int:SPART | |
| Interaction | SERPINA12 interactions | 2.66e-04 | 105 | 170 | 6 | int:SERPINA12 | |
| Interaction | ASF1A interactions | 2.73e-04 | 249 | 170 | 9 | int:ASF1A | |
| Interaction | AR interactions | TPR IRF2BP2 RBL1 POU3F3 MACROH2A1 RAB11FIP1 SRCAP BAP1 BMI1 CCNT1 NCOR1 KMT2C NDRG1 EHMT2 YAP1 CNDP2 DOT1L PLRG1 BAG6 DYNC1H1 | 2.73e-04 | 992 | 170 | 20 | int:AR |
| Interaction | PRKDC interactions | TPR WWP2 LGR4 CHD1L MBD6 BAP1 BMI1 NCOR1 TRIM67 YAP1 CSNK1G2 DOT1L PLRG1 DYNC1H1 NOTCH1 RAD17 | 2.74e-04 | 695 | 170 | 16 | int:PRKDC |
| Interaction | PPP1CA interactions | IRF2BP2 WWP2 BCKDHA RASSF7 AXIN1 BAP1 PPP1R26 BMI1 NCOR1 TRIM67 YAP1 MKI67 UQCRC1 PLRG1 DYNC1H1 PPP1R12C | 2.79e-04 | 696 | 170 | 16 | int:PPP1CA |
| Interaction | PAX6 interactions | IRF2BP2 SRCAP LARP4 BAP1 NCOR1 KMT2C KCNC3 EHMT2 UBXN7 EHMT1 MAF | 2.88e-04 | 366 | 170 | 11 | int:PAX6 |
| Interaction | FBLL1 interactions | 2.88e-04 | 38 | 170 | 4 | int:FBLL1 | |
| Interaction | GNB1 interactions | ZBTB7B BAP1 TRIM67 YAP1 CSNK1G2 GLI1 CSNK1G1 ANKRD11 DOT1L METAP2 | 2.89e-04 | 307 | 170 | 10 | int:GNB1 |
| Interaction | YY2 interactions | 3.05e-04 | 16 | 170 | 3 | int:YY2 | |
| Interaction | RSPO4 interactions | 3.05e-04 | 16 | 170 | 3 | int:RSPO4 | |
| Interaction | AXL interactions | RTN4 TNS2 MACROH2A1 CBL TRIM67 KCNC3 EPHA2 CTTN BAG6 MARCKS DYNC1H1 | 3.08e-04 | 369 | 170 | 11 | int:AXL |
| Interaction | TFAP4 interactions | 3.24e-04 | 153 | 170 | 7 | int:TFAP4 | |
| Interaction | RAB5A interactions | TPR RTN4 KIAA1549 PTPN23 RAB11FIP1 SNX29 JPH1 NCOR1 TRIM67 NDRG1 EPHA2 PYCARD BAG6 MARCKS DYNC1H1 NOTCH1 | 3.26e-04 | 706 | 170 | 16 | int:RAB5A |
| Interaction | ATXN2 interactions | 3.28e-04 | 312 | 170 | 10 | int:ATXN2 | |
| Interaction | TBX2 interactions | 3.52e-04 | 40 | 170 | 4 | int:TBX2 | |
| Interaction | YAP1 interactions | TPR HECW1 RBL1 WWP2 RTN4 SPTBN2 DDN MACROH2A1 SRCAP RASSF7 AXIN1 NCOR1 KMT2C TRIM67 NDRG1 YAP1 GLI1 UBXN7 DOT1L CTTN DYNC1H1 | 3.73e-04 | 1095 | 170 | 21 | int:YAP1 |
| Interaction | KIFAP3 interactions | 3.77e-04 | 112 | 170 | 6 | int:KIFAP3 | |
| Interaction | UHRF1 interactions | 3.95e-04 | 208 | 170 | 8 | int:UHRF1 | |
| Interaction | NCK2 interactions | 3.96e-04 | 262 | 170 | 9 | int:NCK2 | |
| Interaction | CAV1 interactions | WWP2 SPTBN2 KIAA1549 PTPN23 TNS2 RAB11FIP1 SNX29 AXIN1 JPH1 TBC1D10B TRIM67 NDRG1 EPHA2 UBXN7 MARCKS NOTCH1 | 4.30e-04 | 724 | 170 | 16 | int:CAV1 |
| Interaction | HRAS interactions | TPR SLC11A2 KIAA0319L KIAA1549 RALGAPA2 CBL HEPH TBC1D10B PHLDB1 NDRG1 C1orf226 EPHA2 ANKRD11 MARCKS NOTCH1 VAT1 | 4.36e-04 | 725 | 170 | 16 | int:HRAS |
| Interaction | IL31 interactions | 4.38e-04 | 18 | 170 | 3 | int:IL31 | |
| Cytoband | 11q13 | 9.64e-05 | 118 | 176 | 5 | 11q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 4.03e-04 | 8 | 176 | 2 | chr9q12 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 5.23e-05 | 34 | 110 | 4 | 487 | |
| GeneFamily | Ankyrin repeat domain containing | 1.16e-04 | 242 | 110 | 8 | 403 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 1.00e-03 | 8 | 110 | 2 | 837 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.35e-03 | 36 | 110 | 3 | 823 | |
| GeneFamily | Ring finger proteins | 1.47e-03 | 275 | 110 | 7 | 58 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.63e-03 | 206 | 110 | 6 | 682 | |
| GeneFamily | Fibronectin type III domain containing | 2.96e-03 | 160 | 110 | 5 | 555 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.65e-06 | 172 | 176 | 7 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.65e-06 | 172 | 176 | 7 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.60e-06 | 180 | 176 | 7 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.88e-06 | 181 | 176 | 7 | 2f3d04d22d4ac016e61709ea5af3d48885c946c4 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.77e-06 | 184 | 176 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 9.41e-06 | 186 | 176 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.75e-06 | 187 | 176 | 7 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.75e-06 | 187 | 176 | 7 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.01e-05 | 188 | 176 | 7 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 188 | 176 | 7 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.04e-05 | 189 | 176 | 7 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.08e-05 | 190 | 176 | 7 | 9ce301841ce9486701fa28eb2a9929e35d476878 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-05 | 191 | 176 | 7 | 764c3a8829ae1253a0790744138266e81fc075ec | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 195 | 176 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 195 | 176 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 1.32e-05 | 196 | 176 | 7 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.32e-05 | 196 | 176 | 7 | 5bb8653af62334ded8aad48b24b64d7b54bc3cd5 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.37e-05 | 197 | 176 | 7 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_DC1|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.37e-05 | 197 | 176 | 7 | 9a3d0b7f4788487d024d56bc776a2fd1149f50d5 | |
| ToppCell | COVID-19_Severe-Neu_4|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients | 1.41e-05 | 198 | 176 | 7 | bfdddddef9f3f0eb6af013873dec4e06b7c78c58 | |
| ToppCell | COVID-19_Severe-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.46e-05 | 199 | 176 | 7 | 0e327479bbda5a16643cf317d293a2918d619f87 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.51e-05 | 200 | 176 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-05 | 151 | 176 | 6 | 10da94037225a71844281ddcb395072250a78094 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.09e-05 | 159 | 176 | 6 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.39e-05 | 161 | 176 | 6 | bd520c9a1927d5d5355b4421e6b90b58bfb76a42 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.97e-05 | 175 | 176 | 6 | a5db428b078938627e61b7e944c1e0c1d61ac2da | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.97e-05 | 175 | 176 | 6 | 8b498eea1ec1c1f27b171025c3d08adf3687bafc | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.97e-05 | 175 | 176 | 6 | fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.97e-05 | 175 | 176 | 6 | 36c140540497bbe1c5f08fac2d94f08cac18fabb | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.19e-05 | 176 | 176 | 6 | 581d78811b2d99f38a2c7cc268aeb1cf932379c2 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.19e-05 | 176 | 176 | 6 | 77c3da2eaa072a6baefb5087fd07ec18c5e271cd | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.19e-05 | 176 | 176 | 6 | 533d544852038c0612aacf87f4b1c88ff7aace82 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma-3|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 7.28e-05 | 109 | 176 | 5 | 5d194bf95eb777fb4d01bbe5b1639f17ea1bc11a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.66e-05 | 178 | 176 | 6 | 3c973aac16988e88f5677d3d695dd772ccfd6570 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.90e-05 | 179 | 176 | 6 | c7afbd10072d36a35cd20ae73670d76b9cefd22d | |
| ToppCell | 3'_v3-bone_marrow-Mast|bone_marrow / Manually curated celltypes from each tissue | 8.14e-05 | 180 | 176 | 6 | b37ee81b792213d6595b4ec65d04bc35d83321c7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.14e-05 | 180 | 176 | 6 | b6efdb4d319ef6f87f559acd974e5a71b06a2322 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.39e-05 | 181 | 176 | 6 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|bone_marrow / Manually curated celltypes from each tissue | 8.39e-05 | 181 | 176 | 6 | ccd0ed30cea3fb41d34f28b3e8d80a94493bef3c | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 8.92e-05 | 183 | 176 | 6 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.92e-05 | 183 | 176 | 6 | e3ffef2b57dc5b96466dccc9cd54ba326ccf378a | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Monocytic-Cycling_mono|bone_marrow / Manually curated celltypes from each tissue | 8.92e-05 | 183 | 176 | 6 | f10e72a2e2e6cdc1984f469a60244e5fd8a10095 | |
| ToppCell | LA-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 9.00e-05 | 114 | 176 | 5 | ca69dddbdc02fa5718c56362649cd4b9b54f94ce | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.19e-05 | 184 | 176 | 6 | 7712f2e1fae5cdde2d4e355b860dc8536b28e4f6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.47e-05 | 185 | 176 | 6 | 16e9ccea0e3b95d90dc48ef74206c805681dac0b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.47e-05 | 185 | 176 | 6 | cefd81adb480c027545a5c78dcd05669783717f4 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 9.47e-05 | 185 | 176 | 6 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.47e-05 | 185 | 176 | 6 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_pDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.47e-05 | 185 | 176 | 6 | 308a98f111895071d8772bc010554471cc12fab2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.00e-04 | 187 | 176 | 6 | ae2ee6f8e5c37cb88a67f3e742cf86e57657bfaf | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 187 | 176 | 6 | a2076599b33ae6750961b573bfebcb9036fa4ee8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-04 | 188 | 176 | 6 | 6ee3f8f94ea7bdf652c9575fc65bff08070093a4 | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.03e-04 | 188 | 176 | 6 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.03e-04 | 188 | 176 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-04 | 188 | 176 | 6 | c66fccdfe68760b8c3efca77e3c25966dc9a8a5f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 188 | 176 | 6 | 1efbc99bcd6542e5d9fa91edb7c4295167914786 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.03e-04 | 188 | 176 | 6 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.06e-04 | 189 | 176 | 6 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.10e-04 | 190 | 176 | 6 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 1.10e-04 | 190 | 176 | 6 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 191 | 176 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-04 | 191 | 176 | 6 | 06760c3bb40e4f66879a5f5e09c9abfce4ebbba3 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-04 | 191 | 176 | 6 | cadb7a9de16f4bb21606de0e25cddd2d748c7f0b | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 191 | 176 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 191 | 176 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 192 | 176 | 6 | efbd52b3d2b6d3fb9ed6bc3f36aca9f4f1fcbc49 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.16e-04 | 192 | 176 | 6 | 6a252e298f8a454623fa9c1c893a7a45a886d694 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.16e-04 | 192 | 176 | 6 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-04 | 193 | 176 | 6 | 5bee7abc550ddaa28cbb3b9ecaf6b924ab175de0 | |
| ToppCell | droplet-Lung-21m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-04 | 193 | 176 | 6 | 3a5ad8ffad441e30a6e1bd017da7720ad57f6c57 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.23e-04 | 194 | 176 | 6 | 68d15917ae222cba0ad9e716d29eebb6c5f00f69 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.23e-04 | 194 | 176 | 6 | d852aebf7a763b9a776c4570711f0c759f591910 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-04 | 194 | 176 | 6 | 02a9cc821c2b14aa7d0e55661a5fab66364474e1 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.24e-04 | 122 | 176 | 5 | 1ed865f0ecfe304fb86313ff51c04e9052357270 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.26e-04 | 195 | 176 | 6 | 481989d2e5bd2582da3d86b0155c4d6615317067 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.26e-04 | 195 | 176 | 6 | 6108a27523d1b93a7fbe35cb95704a5ad9071e3c | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.26e-04 | 195 | 176 | 6 | fbedb9978ded857fd35c2a8664f7579f42edaa36 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.26e-04 | 195 | 176 | 6 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.26e-04 | 195 | 176 | 6 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 195 | 176 | 6 | cad21edd90bf3e2fefdf5773a59cb1a664a69ddd | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-04 | 195 | 176 | 6 | 3d6d3de8ada6dce3dc789c15b50cc066e7100496 | |
| ToppCell | COVID-19_Severe|World / Disease condition and Cell class | 1.30e-04 | 196 | 176 | 6 | 450ac2aff89c5ca73b8bfbc80663e03be066931f | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-PFC|World / Primary Cells by Cluster | 1.33e-04 | 197 | 176 | 6 | 2c3b0072f8e1e09c77a85c6fc3133d1796932fb2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-04 | 197 | 176 | 6 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.33e-04 | 197 | 176 | 6 | 27c044833e471a312a572e0b1c83e4bc8a36e896 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-04 | 197 | 176 | 6 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.33e-04 | 197 | 176 | 6 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-PFC-29|World / Primary Cells by Cluster | 1.33e-04 | 197 | 176 | 6 | c5bc0e7eb85642b270efc2ba92b13a736af22052 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.33e-04 | 197 | 176 | 6 | 2872a78b1be61aa1d50bc9a49294a21e922dc033 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.33e-04 | 197 | 176 | 6 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | Severe-CD4+_T_Exhausted|World / Disease group and Cell class | 1.41e-04 | 199 | 176 | 6 | 467c34893dd7d1a8a1c101c966f034cc04b9bcbd | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.41e-04 | 199 | 176 | 6 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | Severe-CD4+_T_Exhausted|Severe / Disease group and Cell class | 1.41e-04 | 199 | 176 | 6 | dc6b0291714e2b9501c0796a63678bfb9d1b1052 | |
| ToppCell | normal_Lung-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.41e-04 | 199 | 176 | 6 | 2f6074a2fd3323f258be03042f77929640ad0a75 | |
| ToppCell | ILEUM-inflamed-(6)_ILC-(6)_ILC3|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.41e-04 | 199 | 176 | 6 | 02879df850b0c72b57d7b22cfc43f3407e182dcb | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.41e-04 | 199 | 176 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Globus_pallidus|World / BrainAtlas - Mouse McCarroll V32 | 1.44e-04 | 126 | 176 | 5 | 44b63f945d5bedf1a2ca1810e7e100276ea9dd89 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Neuronal-Neuron|1m / Sample Type, Dataset, Time_group, and Cell type. | 1.45e-04 | 200 | 176 | 6 | be1e153119ca4946b4eaef6037e8465f5c00ca6f | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.45e-04 | 200 | 176 | 6 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | Cerebellum-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.67e-04 | 130 | 176 | 5 | ab141d91988a5de6d092757377a53f7de3707556 | |
| Disease | Adenoid Cystic Carcinoma | 1.88e-05 | 100 | 161 | 6 | C0010606 | |
| Disease | Kleefstra syndrome 1 (implicated_via_orthology) | 2.96e-05 | 2 | 161 | 2 | DOID:0060352 (implicated_via_orthology) | |
| Disease | Connective Tissue Diseases | 4.38e-05 | 13 | 161 | 3 | C0009782 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 7.39e-05 | 41 | 161 | 4 | C0496956 | |
| Disease | Breast adenocarcinoma | 7.39e-05 | 41 | 161 | 4 | C0858252 | |
| Disease | pulse pressure measurement | ZFAT WWP2 LAMA5 PCDHA12 SIPA1 SRCAP LARP4 PRKD3 FBXO38 DIP2A PIEZO2 MALRD1 DENND1B YAP1 SLIT3 ANKRD11 DOT1L BAG6 NUP160 TNS3 | 7.54e-05 | 1392 | 161 | 20 | EFO_0005763 |
| Disease | Charcot-Marie-Tooth disease | 8.13e-05 | 42 | 161 | 4 | cv:C0007959 | |
| Disease | Bladder Neoplasm | 1.23e-04 | 140 | 161 | 6 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.28e-04 | 141 | 161 | 6 | C0005684 | |
| Disease | viral infectious disease (implicated_via_orthology) | 2.93e-04 | 5 | 161 | 2 | DOID:934 (implicated_via_orthology) | |
| Disease | Cerebral Astrocytoma | 3.36e-04 | 25 | 161 | 3 | C0750935 | |
| Disease | Intracranial Astrocytoma | 3.36e-04 | 25 | 161 | 3 | C0750936 | |
| Disease | Astrocytoma | 3.36e-04 | 25 | 161 | 3 | C0004114 | |
| Disease | Grade I Astrocytoma | 3.36e-04 | 25 | 161 | 3 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 3.36e-04 | 25 | 161 | 3 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 3.36e-04 | 25 | 161 | 3 | C0547065 | |
| Disease | Pilocytic Astrocytoma | 3.36e-04 | 25 | 161 | 3 | C0334583 | |
| Disease | Juvenile Pilocytic Astrocytoma | 3.36e-04 | 25 | 161 | 3 | C0280783 | |
| Disease | Diffuse Astrocytoma | 3.36e-04 | 25 | 161 | 3 | C0280785 | |
| Disease | Childhood Cerebral Astrocytoma | 3.36e-04 | 25 | 161 | 3 | C0338070 | |
| Disease | Glioblastoma Multiforme | 3.66e-04 | 111 | 161 | 5 | C1621958 | |
| Disease | Gemistocytic astrocytoma | 3.78e-04 | 26 | 161 | 3 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 3.78e-04 | 26 | 161 | 3 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 3.78e-04 | 26 | 161 | 3 | C0334582 | |
| Disease | sexual dimorphism measurement | ZFAT CD248 RBL1 RTN4 LGR4 PTPN23 SIPA1 SEZ6L2 RNF214 ZNF335 SLIT3 ANKRD11 DOT1L HERC1 SLC22A20P ZNF367 | 3.80e-04 | 1106 | 161 | 16 | EFO_0021796 |
| Disease | Anaplastic astrocytoma | 4.24e-04 | 27 | 161 | 3 | C0334579 | |
| Disease | Colorectal Carcinoma | MKRN3 SLC11A2 CD248 RTN4 SPTBN2 OTOP2 KMT2C PTPRS YAP1 PYCARD MKI67 MAF | 4.97e-04 | 702 | 161 | 12 | C0009402 |
| Disease | central nervous system cancer | 6.41e-04 | 31 | 161 | 3 | EFO_0000326 | |
| Disease | Squamous cell carcinoma of lung | 7.04e-04 | 32 | 161 | 3 | C0149782 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 7.30e-04 | 74 | 161 | 4 | DOID:3748 (is_marker_for) | |
| Disease | Scoliosis, unspecified | 8.11e-04 | 8 | 161 | 2 | C0036439 | |
| Disease | Malignant neoplasm of breast | TFAP2D INPP4B MAP3K1 CNTN6 BAP1 NCOR1 NDRG1 YAP1 GLI1 MKI67 ANKRD34A EHMT1 NHS OXSM NOTCH1 | 8.30e-04 | 1074 | 161 | 15 | C0006142 |
| Disease | Glioblastoma | 9.33e-04 | 79 | 161 | 4 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 1.17e-03 | 84 | 161 | 4 | C0334588 | |
| Disease | lung adenocarcinoma (is_marker_for) | 1.23e-03 | 85 | 161 | 4 | DOID:3910 (is_marker_for) | |
| Disease | HOYERAAL-HREIDARSSON SYNDROME | 1.29e-03 | 10 | 161 | 2 | C1846142 | |
| Disease | neutrophil count, basophil count | 1.48e-03 | 224 | 161 | 6 | EFO_0004833, EFO_0005090 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 1.52e-03 | 90 | 161 | 4 | DOID:11832 (biomarker_via_orthology) | |
| Disease | Familial Atypical Mole Melanoma Syndrome | 1.58e-03 | 11 | 161 | 2 | C2314896 | |
| Disease | Neurodevelopmental Disorders | 1.71e-03 | 93 | 161 | 4 | C1535926 | |
| Disease | Charcot-Marie-Tooth disease type 4 | 2.22e-03 | 13 | 161 | 2 | cv:C4082197 | |
| Disease | ulcerative colitis | 2.51e-03 | 335 | 161 | 7 | EFO_0000729 | |
| Disease | beta-amyloid 1-42 measurement, cerebrospinal fluid biomarker measurement | 2.58e-03 | 14 | 161 | 2 | EFO_0004670, EFO_0006794 | |
| Disease | Breast Carcinoma | 2.89e-03 | 538 | 161 | 9 | C0678222 | |
| Disease | Squamous cell carcinoma of the head and neck | 2.90e-03 | 52 | 161 | 3 | C1168401 | |
| Disease | Body Weight | 2.97e-03 | 15 | 161 | 2 | C0005910 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 2.97e-03 | 15 | 161 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | cortical thickness | IRF2BP2 SPTBN2 ESPNL LGR4 POU3F3 MBD6 MAP3K1 ZNF106 VPS13D PHLDB1 COCH MALRD1 DENND1B PAX7 | 3.23e-03 | 1113 | 161 | 14 | EFO_0004840 |
| Disease | Congenital total cataract | 3.38e-03 | 16 | 161 | 2 | C0266539 | |
| Disease | Dyskeratosis Congenita | 3.38e-03 | 16 | 161 | 2 | C0265965 | |
| Disease | Lung Neoplasms | 3.43e-03 | 265 | 161 | 6 | C0024121 | |
| Disease | Malignant neoplasm of lung | 3.49e-03 | 266 | 161 | 6 | C0242379 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 3.81e-03 | 17 | 161 | 2 | cv:C0270914 | |
| Disease | Nuclear non-senile cataract | 4.27e-03 | 18 | 161 | 2 | C1112705 | |
| Disease | Nuclear cataract | 4.27e-03 | 18 | 161 | 2 | C0392557 | |
| Disease | Malignant Neoplasms | 5.39e-03 | 128 | 161 | 4 | C0006826 | |
| Disease | myeloid white cell count | GNPDA1 HLX MACROH2A1 PRX CCNT1 DIP2A NDRG1 CSNK1G1 DOT1L NUP160 TNS3 VAT1 | 5.45e-03 | 937 | 161 | 12 | EFO_0007988 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QAATHQGSGAAPAGI | 86 | Q9ULZ3 | |
| GAAAHQGPLLDRSSE | 86 | P58512 | |
| SFGQNEAGSEPHIEA | 811 | P29374 | |
| AHPSEQALASSLIGG | 1951 | Q6UB99 | |
| AIADSPGHVFAVENG | 221 | A6NF34 | |
| AAAAAASAVGPVHNS | 1661 | Q9NR09 | |
| SNADSRAHPLGDEGG | 51 | Q9H7E9 | |
| AGQKHAGAPEDASQE | 156 | Q7Z4R8 | |
| GTFNLPSDGSAVDVH | 136 | P46379 | |
| HELEADGISCSPAGA | 341 | Q9HCU0 | |
| AAPTALGEAGLAEHS | 666 | Q9HCU0 | |
| EVAGAAVSAGHGLPA | 256 | O75367 | |
| APAASEGNHTDGAEE | 301 | Q92560 | |
| SEGTLSPNHAGVSND | 396 | Q96KQ7 | |
| ALTGVDHSLPQDGSN | 356 | O60563 | |
| NAHGAGSRSLALAPA | 921 | Q8TEK3 | |
| AAADLNSGSDSHPQA | 321 | O94850 | |
| SGEGASEVPHSRQAA | 526 | Q9P241 | |
| GADPSVRDHAGASAL | 101 | Q69YU3 | |
| ADSGQGHANSEKAPL | 421 | Q7Z6R9 | |
| NAEAGHLDPGFLASD | 296 | Q96B23 | |
| ESLLGAPSESHAGAQ | 326 | Q02833 | |
| PAAGNSGTHFVTDAA | 71 | Q9H714 | |
| PDSGDEAQLNGGHSA | 611 | O75943 | |
| AADLLSSSPESQHGG | 1116 | Q9H3S7 | |
| QADFSISPLHGGLDS | 401 | P23759 | |
| GHSAAQVALTETAPG | 86 | Q9HCM3 | |
| NAHATSTPLGDAAEN | 346 | Q9NWU1 | |
| AGAAGLSGQHEEVPA | 291 | Q9NZ53 | |
| ATPAHDAAATGSLAE | 71 | Q6ZVH7 | |
| SDGSFNLLGSDAHLP | 426 | Q96DN6 | |
| GRTPLHAAVSADAQG | 1961 | P46531 | |
| HSAGAPAAKGDSGNE | 3761 | Q8NEZ4 | |
| EAAVLGATGPADSQH | 606 | Q8NFM7 | |
| APSEGLGHSAELAFA | 31 | Q8IVU1 | |
| AVIAAAAAQSGAGPH | 166 | O75444 | |
| EVAASGSHLNGDLDP | 6 | P50579 | |
| PEPEGAAAATAQHSA | 321 | Q96JG8 | |
| PEGLAGASAAALTAH | 61 | Q14774 | |
| DGHIAFNEPGSSLVS | 141 | P46926 | |
| NASEPHNASGAEAAG | 11 | Q14439 | |
| DEGSPAAGEVLNHSD | 731 | Q8IZA0 | |
| ANGAAQDGDTHPSTG | 641 | Q76N89 | |
| GDASAEIQLAVGHAP | 771 | Q8NDA2 | |
| NGLPDLSTTEGSHAF | 4036 | Q8NDA2 | |
| EGASEEGQHFLPTAQ | 6 | O15327 | |
| GELNVDDPTGAHSNA | 376 | Q9HCP0 | |
| EVAAAAQTSGPAHGR | 31 | Q5HYC2 | |
| LDHTENAASGSGPSA | 2856 | Q15751 | |
| STNGELNADDPTAGH | 366 | P78368 | |
| LHDAAAAADSPAGTR | 176 | Q9HDC5 | |
| HPSADAANGSNEDRG | 101 | P35226 | |
| DRGPEDQESHAQGAA | 226 | Q9C098 | |
| HAAVQPGSLDSESGI | 451 | O43660 | |
| LDAPNTEGAHGAEGA | 181 | Q96B70 | |
| QASPGLVLHAGAATS | 126 | P27815 | |
| TSEGAHLDITPNSGA | 366 | Q92597 | |
| HLDITPNSGAAGNSA | 371 | Q92597 | |
| PGAELLQAASGERHS | 21 | Q8IVU3 | |
| IPLAQVAAGGAHSFA | 181 | Q8IVU3 | |
| GPALSAETAHSGAAA | 361 | P13942 | |
| NGDSSHNPVLAATGV | 501 | O94806 | |
| HSNSISVIPDGAFDG | 256 | Q9BXB1 | |
| GDHGESASLGNINPA | 16 | P49281 | |
| DHSPAGSAANTDSGV | 451 | P08151 | |
| AAHGDTAQDSPGALQ | 701 | Q5JSP0 | |
| QTPGHTEELANGAAD | 2926 | P46013 | |
| TGHLGLANASAPSGE | 2296 | O15230 | |
| QSENAPAAGSGHLTV | 741 | Q2PPJ7 | |
| GVHLSSPLASGAVAN | 321 | P31930 | |
| HPQILEAAGNASAGT | 931 | Q13332 | |
| LISDQHADNPVGGDS | 211 | Q7RTS6 | |
| QAAVPLSSETHGGED | 441 | P09923 | |
| DGEVVAESGNNTPAH | 551 | Q6PIJ6 | |
| AGTEPAADHTLGNSS | 1336 | Q5VYJ5 | |
| TLAHFALGADAPGDA | 41 | Q5EBM0 | |
| RGGSHDAPENTLAAI | 71 | Q9NZC3 | |
| PGQAAELRHSAASAA | 16 | Q96BY6 | |
| AGAQLASGTDAAPEA | 86 | A1L170 | |
| QGLAHFPETIAGSDA | 206 | P29317 | |
| SVGAAPNASDGLAHS | 581 | O15169 | |
| EAFDSHGQESSGQLP | 301 | P23610 | |
| SGDVTHPQAGAEDAL | 721 | Q86WJ1 | |
| TPHTGAEDAEQAAGR | 261 | Q96BT3 | |
| VSHATFDDDLPGVGN | 901 | Q5VT06 | |
| EHADGAGQAPATTAL | 256 | A2IDD5 | |
| GGSLAINSPHTDQDI | 81 | Q9UQ52 | |
| LSHNELADSGIPGNS | 236 | P51884 | |
| NGHVKVNGDASPAAA | 36 | P29966 | |
| DGHIAFNEPGSSLVS | 141 | Q8TDQ7 | |
| IAATSGAHPEGNAEL | 46 | Q71RC2 | |
| GGGDAAPLHSVLSNV | 1771 | Q14204 | |
| GEGNLAAAHANTGPE | 751 | P22681 | |
| SGDNSAPSGQEREDH | 76 | Q8IXQ3 | |
| PGAAATTALAGLEAH | 201 | Q14689 | |
| LAAAHNSADEPGPGA | 546 | I6L899 | |
| DVQGPAAAAHDAGIT | 481 | O43405 | |
| HLGADNVSDPTSGLD | 671 | Q6P3S1 | |
| GPANHTEASTNDSGA | 51 | A6NK97 | |
| GHGAEQAAAFPTEDS | 361 | Q9H9B1 | |
| AASLGSAQPTDLGAH | 221 | Q7Z5L9 | |
| HRGPADSLSTAAGAA | 266 | Q7Z5L9 | |
| PGNSLLAAGSIVHSD | 11 | P20264 | |
| KEENGAAAHFPSAAL | 111 | Q9Y466 | |
| GEEGTHVGSAAALDN | 136 | P12694 | |
| HFPLEGASDADIGVN | 151 | Q9UN75 | |
| VDGGPSHFLASATAA | 351 | A6NNC1 | |
| GAHLTESVAAPDSGA | 121 | Q13233 | |
| GAHGEGSLAPSQAKA | 181 | A1L443 | |
| GAHGEGSLAPSQAKA | 181 | Q5VZR2 | |
| VDNAELGSASAHGTP | 6 | Q96HJ5 | |
| AALEHSEQRAGSPGE | 836 | Q9NZ71 | |
| HKSEIANAPDGAGSL | 896 | Q9NQC3 | |
| GGLVTAGHDAPLEAN | 446 | Q14D33 | |
| SGQASVPSELGHGAD | 571 | Q6WKZ4 | |
| HNDSDILFPVSGVGS | 396 | Q8TEQ0 | |
| HGANIAAVNSDGDLP | 156 | Q9BZL4 | |
| SHIFEALLANPEGSG | 96 | Q7Z6W1 | |
| AAAAASSGETPHQVG | 546 | Q5TGY1 | |
| DDAHQGSQGAEALSP | 1561 | Q6T4R5 | |
| PHAEGAAVVAAAGEA | 6 | P28749 | |
| VGERAPDGASQSSHE | 126 | Q5VVP1 | |
| HTDSAEAAPGTIRGD | 126 | O00746 | |
| ANGSHLNDITGPDSV | 686 | Q5QGS0 | |
| LEENVATHGSQDPGS | 936 | Q9BQS7 | |
| GHSFADPASNLGLED | 2251 | O75376 | |
| VGERAPDGASQSSHE | 126 | Q8IWB4 | |
| ESIGSPDLSGHFLAN | 66 | Q86V20 | |
| DQAASSDLLHGAPGF | 151 | Q96FS4 | |
| DGSQDADHSQGRAEP | 616 | Q5T8A7 | |
| ADPGEIANGHRTASD | 706 | Q6UXD5 | |
| GSAGASEVHPSLERA | 151 | Q9HB31 | |
| GEAPGFHVASLSAEA | 2611 | Q9P2P6 | |
| SGAGGISPQHIAQDS | 41 | Q6ZRS2 | |
| DLGALLANSHGASPT | 1036 | Q68CZ2 | |
| LAQHDPSAVAVAGSS | 1196 | Q12769 | |
| LGAEPASNGLVHGSA | 226 | O94993 | |
| REPENHFVGGAEASA | 1151 | Q9UPX8 | |
| AVAAAAGGAAPSHSQ | 521 | P0C7V6 | |
| QDAEAAVAGPSHAPD | 36 | Q96AP0 | |
| PVGSADDGAHSQNEK | 436 | Q96KP4 | |
| AGGHPAEAAAGSAKQ | 81 | Q8N7H1 | |
| PSLLEQAGSEGAFAH | 81 | Q8N5U0 | |
| HGNDISSVPEGSFND | 831 | O75094 | |
| PVESDADHVTAGANG | 166 | Q53QW1 | |
| TEDGAGDASPVLNHA | 346 | P57727 | |
| VGERAPDGASQSSHE | 126 | Q5VYP0 | |
| EQNPGSSAGDTSAAH | 71 | Q8ND24 | |
| GLNPFGDSTHAAAAA | 36 | O60481 | |
| AHQPSASGGAAAAAA | 56 | Q8NHG8 | |
| AAAAASLEHDAAAGP | 61 | Q6ZTA4 | |
| GHSGLANGTVNDEPT | 226 | O00308 | |
| SDASNADGPGFHSLE | 301 | Q96KV7 | |
| AGSDQESHGAQSPLG | 641 | Q9P243 | |
| AAPGEHGSQAAAARA | 111 | Q9C029 | |
| VPHGGAAAEAAGSQE | 81 | Q2QGD7 | |
| TAAASPAGLDLSNGH | 476 | O15156 | |
| APSEAHEAAGAQAGA | 6 | Q13064 | |
| VGERAPDGASQSSHE | 126 | Q5TZJ5 | |
| QLVAEGHPGASQASA | 706 | O15020 | |
| GHPGASQASARAAEL | 711 | O15020 | |
| VGERAPDGASQSSHE | 126 | Q5VU36 | |
| AGHAVSIAQDDAGAD | 6 | Q14247 | |
| TDGFAEAIHSPQVAG | 2146 | P12270 | |
| DPLANGCQGVSEAAH | 301 | Q9BQI7 | |
| AAPSAEAAGGFALHL | 256 | Q9BXM0 | |
| LSNKPSALHGGDADE | 136 | Q6ZSR6 | |
| DTIDEHPGAASGAQT | 1721 | Q9H5I5 | |
| DAGTAGALTPQHVRA | 111 | P46937 | |
| HGAAAATSASAGQAP | 196 | Q4KMP7 | |
| AAHGASPEDFSLTLG | 496 | Q86UU1 | |
| ASDPQHPAASEGAAA | 26 | Q99536 | |
| GTATNHQGLPAVDSE | 376 | O94888 | |
| HNEGPSSAEGKDIAF | 211 | O75541 | |
| LQQAAPSDSDGSSHG | 1216 | Q502W6 | |
| NAHNVTLSPGAAGAA | 76 | Q7RTV3 | |
| ASAALPAAAAAEHSG | 91 | Q7RTV3 | |
| LHVAEPGGGAAAESQ | 846 | Q9H4Z2 | |
| AQAPSTAGAGDVAEH | 11 | Q8N6K4 | |
| TAGAGDVAEHQVAPA | 16 | Q8N6K4 | |
| EPTEGSFEGHQAAVN | 1521 | Q9H2Y7 | |
| GHLASAGPLASAESL | 861 | Q63HR2 | |
| VHAAGAAEAGPLASV | 271 | Q96H79 | |
| ALGLALNVPGSSSHD | 176 | O95407 | |
| GPNVAHLTDGATLND | 1046 | Q5THJ4 | |
| DPAGAANAANAAGAH | 206 | Q14003 | |
| PAAGDVIDGSDHSVA | 761 | Q5VV43 | |
| EEDSPRALGSGQHSD | 1356 | O15069 | |
| HSTQGAGPAAEDAFS | 96 | Q86VE0 | |
| TDAIEASSIGFNPGH | 246 | P29120 |